exposing Parkinson's disease's voices and faces.

Published Date: 26 Apr 2023

One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.

Read Full News

Latest News

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care

Assay measures phosphorylated tau 217, an indicator of amyloid pathology

Dementia Drug Helpful With Lupus Brain Fog

Cognitive function improved in small placebo-controlled trial

Controversial Neurologist to Lead NIH Unit; Hunter Trial Halted; Dads and Valproate

News and commentary from the world of neurology and neuroscience

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Latest News

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

Assay measures phosphorylated tau 217, an indicator of amyloid pathology

Cognitive function improved in small placebo-controlled trial

News and commentary from the world of neurology and neuroscience

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

News All Time

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Alzheimer's and Liver Enzymes; Pivotal Trial Hold; Lasker Awards Honor Brain Science

News and commentary from the world of neurology and neuroscience

Aging Doctors Face a Patchwork of Cognitive Screening Policies, Study Shows

Unlike pilots, judges, and air traffic controllers, physicians rely largely on self-regulation

Trump's Surgeon General Pick Grilled Over Vaccine Stance

"I do not believe childhood vaccines cause autism," Saphier said

Case Report: What Caused This Man's Acute Paralysis?

36-year-old Asian man had epidural steroid injection for persistent back pain after unsuccessful chiropractic treatments

Man Presents With Episodic, One-Sided Facial Paralysis

Uncommon presentation of MS detailed in case report

FDA-Ordered Studies for Drugs and Devices on the Market for Years Still Aren't Done

Agency's reliance on postmarketing studies reflects a balancing act

Gene Therapy for Sanfilippo Syndrome Gets FDA Nod

Treatment is the first for MPS type IIIA

Depression Drug Trials Paused Over Side-Effect Concerns

Xenon Pharmaceuticals on Thursday said it has temporarily paused enrolling new patients in clinical studies testing ⁠its experimental drug for major and bipolar depression,...

The 90-Day CPAP Cutoff May Be Too Soon to Measure Success

Data presented at the American Thoracic Society (ATS) 2026 show many early CPAP nonadherers reach clinically meaningful use within a year, challenging CMS's rigid 90 day coverage rule.

‘Good First Try’: In Vivo CAR T for Neuro Autoimmune Disease

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Which Therapies Offer the Lowest Relapse Rates in Early MS?

Patients with MS starting B-cell therapies had fewer relapses and less T2 lesion growth, but no measurable difference in disability after 2 years.

Recommended News For You

Weight loss trial reports success for breast cancer patients at one year mark

Sevabertinib Approved for First-Line Mutated NSCLC

No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire

Aster Whitefield Hospital, with 506 beds, opened.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

Recommended Articles For You

Spatial Pharmacology Within the Tumor Microenvironment: Precision in Oncologic Therapeutics 

Targeted Therapies for Breast Cancer: What’s New? 

Tumor Microenvironment Secretome Mapping in Cancer Biology 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

2.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

3.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

4.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

5.

Ranking of the Best US Hospitals for Psychiatric Care.

1.

New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD)

2.

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management

3.

Strategic Applications in Hematology in Clinical Decision-Making

4.

Obesity is a major risk factor for cancer

5.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Evidence-Based Oncology

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot